These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
1056 related items for PubMed ID: 18163551
41. [Relationship between the anti-metastatic effect of UFT and in vitro chemosensitivity to 5-FU in metastatic tumors from orthotopic implanted colon cancer in nude rats]. Ogata Y, Akagi Y, Nozoe Y, Sasatomi T, Miyagi Y, Nakagawa M, Matono K, Kobayashi H, Shirouzu K. Gan To Kagaku Ryoho; 2001 May; 28(5):655-60. PubMed ID: 11383214 [Abstract] [Full Text] [Related]
42. Synthesis and in vivo antitumor evaluation of 2-methoxyestradiol 3-phosphate, 17-phosphate, and 3,17-diphosphate. Edsall AB, Agoston GE, Treston AM, Plum SM, McClanahan RH, Lu TS, Song W, Cushman M. J Med Chem; 2007 Dec 27; 50(26):6700-5. PubMed ID: 18052315 [Abstract] [Full Text] [Related]
43. Biological characterization of a novel antitumor quinolone. Clement JJ, Burres N, Jarvis K, Chu DT, Swiniarski J, Alder J. Cancer Res; 1995 Feb 15; 55(4):830-5. PubMed ID: 7850797 [Abstract] [Full Text] [Related]
44. Combined effects of the oral fluoropyrimidine anticancer agent, S-1 and radiation on human oral cancer cells. Harada K, Kawaguchi S, Supriatno, Onoue T, Yoshida H, Sato M. Oral Oncol; 2004 Aug 15; 40(7):713-9. PubMed ID: 15172641 [Abstract] [Full Text] [Related]
47. Synthesis and preclinical evaluations of 2-(2-fluorophenyl)-6,7-methylenedioxyquinolin-4-one monosodium phosphate (CHM-1-P-Na) as a potent antitumor agent. Chou LC, Chen CT, Lee JC, Way TD, Huang CH, Huang SM, Teng CM, Yamori T, Wu TS, Sun CM, Chien DS, Qian K, Morris-Natschke SL, Lee KH, Huang LJ, Kuo SC. J Med Chem; 2010 Feb 25; 53(4):1616-26. PubMed ID: 20102207 [Abstract] [Full Text] [Related]
48. Synthesis and antitumor effect in vitro and in vivo of substituted 1,3-dihydroindole-2-ones. Christensen MK, Erichsen KD, Trojel-Hansen C, Tjørnelund J, Nielsen SJ, Frydenvang K, Johansen TN, Nielsen B, Sehested M, Jensen PB, Ikaunieks M, Zaichenko A, Loza E, Kalvinsh I, Björkling F. J Med Chem; 2010 Oct 14; 53(19):7140-5. PubMed ID: 20845961 [Abstract] [Full Text] [Related]
50. Cytotoxicity and antitumor activity of carzelesin, a prodrug cyclopropylpyrroloindole analogue. Li LH, DeKoning TF, Kelly RC, Krueger WC, McGovren JP, Padbury GE, Petzold GL, Wallace TL, Ouding RJ, Prairie MD. Cancer Res; 1992 Sep 15; 52(18):4904-13. PubMed ID: 1516047 [Abstract] [Full Text] [Related]
51. Three new prodrugs for suicide gene therapy using carboxypeptidase G2 elicit bystander efficacy in two xenograft models. Friedlos F, Davies L, Scanlon I, Ogilvie LM, Martin J, Stribbling SM, Spooner RA, Niculescu-Duvaz I, Marais R, Springer CJ. Cancer Res; 2002 Mar 15; 62(6):1724-9. PubMed ID: 11912146 [Abstract] [Full Text] [Related]
53. A novel prodrug of the green tea polyphenol (-)-epigallocatechin-3-gallate as a potential anticancer agent. Landis-Piwowar KR, Huo C, Chen D, Milacic V, Shi G, Chan TH, Dou QP. Cancer Res; 2007 May 01; 67(9):4303-10. PubMed ID: 17483343 [Abstract] [Full Text] [Related]
54. Identification of a potent and stable antiproliferative agent by the prodrug formation of a thiolate histone deacetylase inhibitor. Suzuki T, Hisakawa S, Itoh Y, Maruyama S, Kurotaki M, Nakagawa H, Miyata N. Bioorg Med Chem Lett; 2007 Mar 15; 17(6):1558-61. PubMed ID: 17257837 [Abstract] [Full Text] [Related]